Advances in Therapy

, Volume 36, Issue 11, pp 3186–3195 | Cite as

Comparative Impact of C-Reactive Protein Testing in Hospitalized Patients with Acute Respiratory Tract Infection: A Retrospective Cohort Study

  • Olivier Giannini
  • Rosaria Del GiornoEmail author
  • Anna Zasa
  • Luca Gabutti
Original Research



Evidence-based data on the usefulness of C-reactive protein (CRP) monitoring in patient outcomes are lacking. CRP testing in patients with acute respiratory tract infections (ARTIs) showed wide variability between internal medicine wards in our hospital network. In this study we aimed to investigate whether repetitive CRP tests might influence the switch of antibiotic therapy from intravenous (IV) to oral (PO) route and whether CRP measurements affect the combined outcome of readmission and in-hospital mortality.


This was a retrospective cohort study conducted in two internal medicine wards selected in a network of five teaching hospitals on the basis of their CRP prescription frequency. Clinical and laboratory data of 296 patients with ARTIs and admitted from 1 January to 31 December 2016 were analyzed.


The mean ± SD of CRP tests/patient and the in-hospital length of antibiotic therapy (days) in the low-CRP (L-CRP) vs the high-CRP (H-CRP) wards were 1.14 ± 0.62 vs 3.43 ± 1.54 (p < 0.001) and 7.1 ± 2.6 vs 7.5 ± 3.2 (p = 0.298), respectively. The probability of antibiotic switching was higher in the L-CRP ward (HR 2.90, 95% CI 1.69–4.95, p < 0.001) correlating with the lower number of CRP determinations (HR 1.20, 95% CI 1.01–1.41, p = 0.034). In-hospital readmissions and mortality rates did not significantly differ between the two wards (L-CRP 17.1% vs H-CRP 10.0%, p = 0.133). The number of CRP determinations affected the combined outcome (OR 1.38, 95% CI 1.01–1.90, p = 0.043).


Repetitive CRP testing in ARTIs offers no added value to either antibiotic switch or patient outcomes in hospitalized patients in internal medicine wards.


Antibiotic therapy C-reactive protein Choosing Wisely Infectious disease Primary and hospital care Respiratory tract infections 




No funding or sponsorship was received for this study or publication of this article. The Rapid Service Fee was funded by the authors. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.


All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Authorship Contributions

Olivier Giannini and Rosaria Del Giorno contributed equally to this work.


Olivier Giannini, Rosaria Del Giorno, Anna Zasa and Luca Gabutti declare that they have no conflicts of interest.

Compliance with Ethics Guidelines

The study was conducted in accordance with the Declaration of Helsinki. The study was exempt from institutional review board approval by the Swiss Ethics Committee because it involved anonymous secondary data only. Informed consent was not obtained because the data were from de-identified and previously collected administrative data.

Data Availability

The dataset analyzed during the current study is available from the corresponding author on reasonable request.


  1. 1.
    American Society of Clinical Pathology Recommendations. Choosing Wisely Campaign. Updated February 2, 2015.
  2. 2.
    Konger RL, Ndekwe P, Jones G, et al. Reduction in unnecessary clinical laboratory testing through utilization management at a US government Veterans Affairs hospital. Am J Clin Pathol. 2016;145(3):355–64.CrossRefGoogle Scholar
  3. 3.
    Melendez-Rosado J, Thompson KM, Cowdell JC, et al. Reducing unnecessary testing: an intervention to improve resident ordering practices. Postgrad Med J. 2017;93:476–9.CrossRefGoogle Scholar
  4. 4.
    Perrig M, Beck T, Wertli M, Donzé J, Rodondi N, Aujesky D. Rationale Labortests in der stationären Allgemeinen Inneren Medizin. Schweiz Ärtzteztg. 2018;99:1266–9.Google Scholar
  5. 5.
    American Board of Internal Medicine (ABIM) Foundation. Choosing Wisely. About the Campaign, 2015. Updated November 25, 2015.
  6. 6.
    Horvath K, Semlitsch T, Jeitler K, et al. Choosing Wisely: assessment of current US top five list recommendations’ trustworthiness using a pragmatic approach. BMJ Open. 2016;6(10):e012366.CrossRefGoogle Scholar
  7. 7.
    Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkensand PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract. 2003;53(490):358–64.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Jain S, Self WH, Wunderink RG. Community-acquired pneumonia requiring hospitalization. N Engl J Med. 2015;373(24):415–27.CrossRefGoogle Scholar
  9. 9.
    Erard Y, Del Giorno R, Zasa A, et al. A multi-level strategy for a long lasting reduction in unnecessary laboratory testing: a multicenter before and after study in a teaching hospital network. Int J Clin Pract. 2018;73:e13286.CrossRefGoogle Scholar
  10. 10.
    Ellenbogen MI, Ma M, Christensen NP, Lee J, O’Leary KJ. Differences in routine laboratory ordering between a teaching service and a hospitalist service at a single academic medical center. Southern Med. 2017;110(1):25–30.CrossRefGoogle Scholar
  11. 11.
    Sirovich BE, Lipner RS, Johnston M, Holmboe ES. The association between residency training and internists’ ability to practice conservatively. JAMA Intern Med. 2014;174:1640–8.CrossRefGoogle Scholar
  12. 12.
    Parekh V, Saint S, Furney S, Kaufman S, McMahon L. What effect does inpatient physician specialty and experience have on clinical outcomes and resource utilization on a general medical service? J Gen Intern Med. 2004;19:395–401.CrossRefGoogle Scholar
  13. 13.
    Lobo SM. Sequential C-reactive protein measurements in patients with serious infections: does it help? Lobo Critical Care. 2012;16:130.CrossRefGoogle Scholar
  14. 14.
    Bruns AHW, Oosterheert JJ, Hak E, Hoepelman AIM. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J. 2008;32:726–32.CrossRefGoogle Scholar
  15. 15.
    Coelho L, Pòvoa P, Almeida E, et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care. 2007;11:R92.CrossRefGoogle Scholar
  16. 16.
    Spegiorin Moreno M, Nietmann H, Murilo Matias C, Lobo SM. C-reactive protein: a tool in the follow-up of nosocomial pneumonia. J Infect. 2010;61(3):205–11.CrossRefGoogle Scholar
  17. 17.
    Almirall J, Bolibar I, Toran P, et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired penumonia. Chest. 2004;125:1335–42.CrossRefGoogle Scholar
  18. 18.
    Uranga A, España PP, Bilbao A, Quintana JM, Arriaga I, Intxausti M. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Internal Med. 2016;176(9):1257–65.CrossRefGoogle Scholar
  19. 19.
    Spellberg B. The new antibiotic mantra-“shorter is better”. JAMA Intern Med. 2016;176(9):1254–5.CrossRefGoogle Scholar
  20. 20.
    Alm EA, Switzer GE, Mittman BS, Walsh MBRN, Chang CCH, Fine MJ. What factors influence physicians’ decisions to switch from intravenous to oral antibiotic for community-acquired pneumonia? J Gen Intern Med. 2001;16:599–605.CrossRefGoogle Scholar
  21. 21.
    Dahler-Eriksen BS, Lauritzen T, Lassen JF, Lund ED, Brandslund I. Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clin Chem. 1999;45(4):478–85.PubMedGoogle Scholar
  22. 22.
    Cals JW, Ament AJ, Hood K, et al. C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial. J Eval Clin Pract. 2011;17(6):1059–69.CrossRefGoogle Scholar
  23. 23.
    Oppong R, Jit M, Smith RD, et al. Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions. Br J Gen Pract. 2013;63(612):e465–71.CrossRefGoogle Scholar
  24. 24.
    Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10:CD007498.PubMedGoogle Scholar

Copyright information

© Springer Healthcare Ltd., part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Internal Medicine and Service of NephrologyEnte Ospedaliero Cantonale (EOC), Ospedale Regionale della Beata VergineMendrisioSwitzerland
  2. 2.Department of Internal Medicine and Service of NephrologyEnte Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e ValliBellinzonaSwitzerland
  3. 3.Quality and Patient Safety ServiceEnte Ospedaliero Cantonale (EOC), Ospedale La CaritàLocarnoSwitzerland
  4. 4.Institute of Biomedicine, University of Southern Switzerland (USI)LuganoSwitzerland

Personalised recommendations